Professionals 26 results
Capabilities 6 results
Practice Area
Practice Area
Practice Area
Experience 12 results
Experience
|October 13, 2021
US$1.18B Green Financing for First North American Flood Prevention P3
Experience
|April 1, 2021
Revelstoke's Carrus Acquires Archetype Innovations
Experience
|February 1, 2021
Norwest Equity Partners' Investment in Recteq
Insights & News 47 results
Competition Corner
|July 28, 2025
|9 Min Read
New Legislation and Enforcement Initiatives: The State Enforcement Future and Impact
As federal antitrust enforcement continues to evolve, adjust priorities, and in some cases, stall out, states are increasingly enhancing their enforcement focus, resources, and law.
Client Alert
|March 5, 2025
|5 Min Read
Current Status of White House Executive Order on Gender-Affirming Care
On March 4, 2025, in response to a lawsuit by several civil rights organizations and individuals against the federal government’s policy directives on gender-affirming care, a federal court issued a partial block of Executive Order 14187 titled “Protecting Children from Chemical and Surgical Mutilation” and Executive Order 14168 titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government.”
Product Liability & Mass Torts Digest
|September 18, 2024
|3 Min Read
Microplastics Policy: Is Federal Preemption a Viable Defense?
There are myriad examples of lawsuits ensuing after a regulatory body or other agency issues a statement or report on a particular substance. As things currently stand, however, statements by the U.S. Food and Drug Administration (FDA) may offer a defense to claims involving microplastics.
Other Results 11 results
Location
Location